For more than 10 years, Protéus has been working on proteins from the most diverse origins. This outstanding know-how in recombinant expression in micro-organisms and process development has enabled the Company to create a comprehensive platform of services to address recombinant protein expression challenges.
Protéus supports the continuous growth of biopharmaceuticals by providing opportunities to accelerate R&D programs, whether for princeps drugs or biosimilars. Our comprehensive range of services is dedicated to providing optimal expression conditions, immunogenicity management and protein engineering capabilities..
A dedicated business unit has been designed to better serve the biotech and pharmaceutical industry with this comprehensive protein-related services platform. Visit our dedicated website (www.proteus-psi.com) to know more.
Download more about Innovation for Healthcare at Protéus (pdf)